论文部分内容阅读
因病例所限,有关脑少支胶质细胞瘤的术后情况及放射敏感性研究甚少,对此类病人术后是否给予放疗并无明确答案。本研究分析了挪威25年期间,该病的组织学与放疗情况,这有利于估价手术效果及术后放疗剂量。临床资料和方法:1953～1977年25年期间所有病例均经组织学诊断为少支胶质细胞瘤或恶性少支胶质细胞瘤,均位于幕上。197例行开颅手术。其中22例术后30天内死亡,另5例是否进行过放疗记录不详,未包括在本研究内。仅几例病人给予常规放疗(200 KV,15mA),多数病人于术后3月内接受了高强度放疗,剂量为1.8～2.0 Gy/天。因放疗指
Due to the limited number of cases, there are few studies on the postoperative conditions and radiosensitivity of oligodendrocyte glioblastoma. There is no definitive answer to whether or not radiotherapy is given to such patients after surgery. This study analyzed the histology and radiotherapy of the disease during the 25 years in Norway, which is helpful to evaluate the surgical effect and postoperative radiotherapy dose. Clinical data and methods: From 1953 to 1977, all cases were histologically diagnosed as glioblastomas or malignant oligodendrogliomas, all located on the screen. 197 routine craniotomy. Twenty-two of these patients died within 30 days after surgery. The other 5 patients who had undergone radiotherapy records were not known and were not included in this study. Only a few patients were given conventional radiotherapy (200 KV, 15 mA), and most patients received high-intensity radiotherapy within 3 months after surgery. The dose ranged from 1.8 to 2.0 Gy/day. Due to radiotherapy